All In Biotech

Drug Trial Radar · NCT04949633

Oxytocin vs Prostaglandins for Labor Induction of Women With an Unfavorable Cervix After 24h of Cervical Ripening

Oxytocine Versus Prostaglandines Pour le déclenchement du Travail Des Femmes Dont le Col Est défavorable après 24 Heures de Maturation Cervicale : Essai Multicentrique randomisé de Non infériorité

Last checked: Nov 20, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 1,494 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

1,494

Planned (sponsor's estimate)

Start

Sep 28, 2021

Primary completion

Sep 2027

Study completion Nov 2027

Sponsor

Lead sponsor
University Hospital, ToursAcademic, hospital or other
Sponsor type
Academic, hospital or other
First posted
Jul 2, 2021

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Female only, from 18 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

Twenty-two percent of deliveries in France are induced. In cases where labor is induced and cervix is unfavorable, cervical ripening prior oxytocin administration is advised in order to reduce the risk of cesarean delivery. Cervical ripening agents, pharmacological (prostaglandins) or mechanical are administered during 24 hours. After 24 hours, most women will be either delivered or in labor but 25% of women will require further induction of labor. For 16% of women who undergo cervical ripening, whatever the cervical ripening method, the cervix remains unchanged after 24 hours. The management of these women is not consensual and depends on the maternity unit where women are cared for. This study seeks to identify the most appropriate strategy for the management of women with an unfavorable cervix after 24 hours of cervical ripening, a strategy which would be associated with the lowest maternal and perinatal morbidity but also with the best maternal satisfaction. Because both strategies are practiced in France, the trial would compare: induction of labor with oxytocin and repeated cervical ripening. The aim is to show that repeating cervical ripening is an unnecessary procedure. And more specifically that oxytocin administration is not associated with a higher caesarean delivery rate and that it reduces the time to delivery in comparison with cervical ripening with prostaglandins.

Conditions

  • Cervical Ripening
  • Unfavorable Cervix

Interventions

  • ProstaglandinsDrug

    Second cervical ripening lasting a maximum of 24 hours

  • OxytocinDrug

    Induction of labor with oxytocin.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Cesarean delivery rateTime frame: Up to 2 days after intervention

Locations

14 sites in 1 country. Site status is shown where the registry gives one.

  • Gynaecology-obstetrics, University Hospital, Angers

    Angers, France · Recruiting

  • Gynaecology-obstetrics, University Hospital, Bordeaux

    Bordeaux, France · Terminated

  • Gynaecology-obstetrics, University Hospital, Brest

    Brest, France · Recruiting

  • Gynaecology-obstetrics, University Hospital, Clermont-Ferrand

    Clermont-Ferrand, France · Terminated

  • Gynaecology-obstetrics, Hospital St Joseph, Marseille

    Marseille, France · Terminated

  • Gynaecology-obstetrics, University Hospital, Nancy

    Nancy, France · Recruiting

  • Gynaecology-obstetrics, University Hospital, Nantes

    Nantes, France · Recruiting

  • Gynaecology-obstetrics, University Hospital, Orléans

    Orléans, France · Recruiting

  • Gynaecology-obstetrics, Port Royal Maternity Hospital, Paris

    Paris, France · Recruiting

  • Gynaecology-obstetrics, University Hospital, Poitiers

    Poitiers, France · Terminated

  • Gynaecology-obstetrics, Hospital, Pontoise

    Pontoise, France · Not yet recruiting

  • Gynaecology-obstetrics, University Hospital, Saint Etienne

    Saint-Etienne, France · Recruiting

  • Gynaecology-obstetrics, University Hospital, Strasbourg

    Strasbourg, France · Not yet recruiting

  • Gynaecology-obstetrics, University Hospital, Tours

    Tours, France · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.